Company / EPS (Basic)
Chemed Corp. EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$18.11
FY2025
5-year range
$13.77 / $20.02
FY2021-FY2025
Trend
+8.3%
vs FY2024
Sector context
#8 of 160
Health Care
What the data says
Among 160 Health Care companies, Chemed Corp. is in the top 5% for eps (basic). EPS (Basic) returned to growth in FY2025 after 2 years of decline, reaching $18.11.
Based on SEC 10-K filings.
18.11 in FY2025 with a 5-year CAGR of +7.2%. Top quartile in the Health Care sector.
Improved from $17.14 to $18.11 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -3.3%
- 5-Year CAGR
- +7.2%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 160This company $18.11 Sector average $1.66
▼
+993.5% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 8.3% year-over-year.
- Ranks #8 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2022.
- Lowest eps (basic) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.11 | +8.3% |
| FY2024 | $16.72 | -2.5% |
| FY2023 | $17.14 | -14.4% |
| FY2022 | $20.02 | +45.4% |
| FY2021 | $13.77 | +7.6% |
| FY2020 | $12.80 | +109.5% |
| FY2019 | $6.11 | -8.0% |
| FY2018 | $6.64 | +1.5% |
| FY2017 | $6.54 | +13.0% |
| FY2016 | $5.79 | +36.6% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026